Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Accepted on 11 Aug 2025

Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy

in Respiratory Pharmacology

Ben Wang
Xueling Wu
Yu Zhong
Chaowang Huang
Zhi Xu
Liang Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1552034

Original Research

Published on 08 Aug 2025

The first step for understanding the molecular mechanism of the antifibrotic effect of inhaling 25(OH)-vitamin D3 and 1,25(OH)2-vitamin D3 in the murine model of hypersensitivity pneumonitis

in Respiratory Pharmacology

Marta Kinga Lemieszek
Michał Chojnacki
Iwona Paśnik
Alicja Wilczyńska
Wiktoria Gawryś
Jakub Anisiewicz
Ilona Leśniowska
Michał Kiełbus

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1610165

296 views

Review

Published on 08 Aug 2025

Efficacy and safety of reduning injection for severe pneumonia: a systematic review and meta-analysis

in Respiratory Pharmacology

Yan Wang
Baichuan Xu
Peng Zhang
Suyun Li
Yang Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1591136

399 views

Correction

Published on 07 Aug 2025

Correction: Novel mitophagy inducer TJ0113 alleviates pulmonary inflammation during acute lung injury

in Respiratory Pharmacology

Zhengyuan Liu
Danruo Fang
Kaijun Chen
Lingling Dong
Huaqiong Huang
Zhihua Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667879

195 views

Case Report

Published on 06 Aug 2025

NTRK1-fusion as an acquired resistance mechanism in EGFRex19 mutated NSCLC: a case report

in Respiratory Pharmacology

Jielin Li
Yunyun Shi
Mengge Zheng
Chenkang Yang
Hong Gao
Xiaoling Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571777

494 views

Review

Published on 31 Jul 2025

Gut-lung axis in allergic asthma: microbiota-driven immune dysregulation and therapeutic strategies

in Respiratory Pharmacology

Jian Lv
Yu Zhang
Shuang Liu
Ruoyu Wang
Jianan Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1617546

438 views

Original Research

Published on 30 Jul 2025

Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis

in Respiratory Pharmacology

Yuejiao Lan
Cuiting Dong
Mingda Wu
Ruichen Yuan
Kunpeng Yang
Zhen Yang
Yang Chen
Jingbin Zhang
Bingxue Qi
Xiaodan Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594757

564 views

Review

Accepted on 28 Jul 2025

Unlocking the secrets of glucose metabolism reprogramming: The role in pulmonary diseases

in Respiratory Pharmacology

Zhen Li
Shuoxuan Chen
Shuai Jiang
Yinong Yang
Xichan Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1551452

Original Research

Accepted on 25 Jul 2025

Optimization of Ivacaftor-loaded Solid Lipid Nanoparticles for Solubility Enhancement

in Respiratory Pharmacology

Akshay Parihar
Bhupendra Gopalbhai Prajapati
Himanshu Paliwal

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1619481

211 views

Clinical Trial

Published on 25 Jul 2025

Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial

in Respiratory Pharmacology

Cuiyun Li
Jixuan Sun
Jia Xu
Min Wu
Xiaojiao Li
Zhijie Liu
Qingfeng Dong
Yu Sun
Yanhua Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1580883

431 views

Original Research

Published on 23 Jul 2025

The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study

in Respiratory Pharmacology

Alida Benfante
Alessandra Tomasello
Lorena Gentile
Alessia Leonarda Lisotta
Paola Marasà
Salvatore Battaglia
Nicola Scichilone

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1611168

509 views

Review

Published on 16 Jul 2025

Mapping the oxidative landscape in cystic fibrosis: methodological frontiers and application

in Respiratory Pharmacology

Michela Rubin
Ilaria Artusi
Giorgio Cozza

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632924

1,046 views

Original Research

Published on 10 Jul 2025

EPA-lactone derivative, 5,6-diHETE lactone, improves pulmonary arterial hypertension in a monocrotaline-induced model

in Respiratory Pharmacology

Karthik Dhananjayan
Offir Ertracht
Shaul Atar
Alejandro Livoff
Mona Shehadeh
Andrea Szuchman-Sapir

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1621030

1,049 views

Original Research

Published on 09 Jul 2025

Novel mitophagy inducer TJ0113 alleviates pulmonary inflammation during acute lung injury

in Respiratory Pharmacology

Zhengyuan Liu
Danruo Fang
Kaijun Chen
Lingling Dong
Huaqiong Huang
Zhihua Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1590458

1,067 views

Case Report

Published on 09 Jul 2025

Case Report: Coadministration of TNF-α blockade as an effective adjunctive strategy in the treatment of ANCA-negative EGPA with refractory peripheral neuropathy

in Respiratory Pharmacology

Dabin Tang
Yubao Jiang
Shuo Yang
Jiaxin Wei
Jingjing Xie
Jianyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555377

772 views

Original Research

Accepted on 04 Jul 2025

Active Surveillance of Adverse Drug Events in Hospitalized Patients with Pulmonary Arterial Hypertension Based on the Global Trigger Tool

in Respiratory Pharmacology

Mengdan Xu
Suzhen He
Guozhi Li
Shunyu Xiong
Guanquan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533634

196 views